Results In HF, compared to sham-operated control
Onoharigho RA, Crook M, Jalil M, Godschall EN, Dame EG, Dawer A, Belmont-Rausch DM, Pers TH, Lutas A, Habib N, Gler AD, Krashes MJ, Campbell JN (2024) Molecular connectomics reveals a glucagon-like peptide 1-sensitive neural circuit for satiety
Nov 05, 2025, 08:15 ET Post hoc analyses include data showing investigational oral semaglutide 25 mg use was associated with improvements in blood sugar control and cardiovascular (CV) risk factors across multiple categories of weight loss 1 Another analysis detailed an indirect trial comparison between oral semaglutide 25 mg and the currently available injectable form, showing comparable efficacy 2 In two additional analyses, oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively 3,4 PLAINSBORO, N.J
The medication activates GIP and GLP-1 receptors simultaneously
Does semaglutide permanently change your appetite
Ryther RC, Wong M